glp-1 and suicidal ideation Exploration of the potential association between receptor agonists or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database | BMC Medicine New data provide 'much-needed reassurance'
Description
This class has gained popularity and attention in recent years due to its potential to combat obesity
Death by any cause was 13% lower among patients treated with GLP-1 receptor agonists
Available in Strengths of 50mg & 100mg.
Science translational medicine
Within that group, 40% reported symptoms such as irregular menstrual cycles, delayed ovulation, or diminished sperm quality
